
A Monthly Pill Could Transform HIV Treatment And Prevention
Tens of thousands of people living with HIV may soon swap their daily regimen of pills for a single tablet taken once a month. A landmark trial has found the new medication, developed by pharmaceutical giant Merck, to be as effective as the daily drug combinations currently used to keep the virus under control.
The pill belongs to a new class of drugs known as nucleoside reverse transcriptase translocation inhibitors, or NRTTIs. It works by blocking a critical step in the virus’s replication process, preventing HIV from embedding itself into the DNA chain. Researchers say the simplified dosing schedule could …












